© Reuters Abbott Labs profit and revenue beat expectations in Q3.
Investing.com – Abbott Labs (NYSE: ) Q3 Report Beats Analyst Estimates. with higher-than-expected earnings, according to reports on Wednesday
Abbott Labs’ earnings per share (EPS) came in at $1.14 on revenue of $10.1B, compared to the analyst consensus that Investing.com had previously estimated at $1.10 per share on revenue of $9.82B.
Shares of Abbott Labs added 2.43% to $94.38 in premarket trading. After the news of earnings report
Besides Abbott Labs, there are other companies. The New York Stock Exchange’s health sector reported operating results this month
UnitedHealth previously estimated Q3 earnings at $6.56 per share on revenue of $92.4B, and $6.33 per share on revenue of $91.42B.
Meanwhile, J&J’s latest results beat analyst forecasts. Q3 earnings of $2.66 per share on revenue of $21.4B, beating analyst estimates for 2020. Investing.com expects EPS to be around $2.51 on revenue of $21.04B.
Follow the latest developments in company profits with the Investing.com Earnings Calendar
“Avid gamer. Social media geek. Proud troublemaker. Thinker. Travel fan. Problem solver.”